Results 191 to 200 of about 3,334,579 (366)

Application of a Saliva‐Based Liquid Biopsy for the Detection of HPV in Patients With Oral Cavity Squamous Cell Carcinoma (OCSCC)

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Human papilloma virus (HPV) is a DNA virus capable of infecting mucous membranes. In most cases, the infection is cleared by the immune system, but a prolonged exposure to HPV can progress to cancer. 40%–60% of head and neck squamous cell carcinomas (HNSCC) are linked to HPV, which is considered a risk factor especially among young ...
Michela Bulfoni   +12 more
wiley   +1 more source

Severe Drug-Induced Dermatosis in a Geriatric Patient: A Case Report. [PDF]

open access: yesCureus
Saldaña Guerrero S   +2 more
europepmc   +1 more source

Liquid Biopsies in Head and Neck Cancers: Recent Developments Across Biofluids, Analytes, and Molecular Features

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Head and neck cancers (HNCs) are too often diagnosed at advanced stages when outcomes are poor. Additionally, robust tools for the early detection of recurrence remain elusive. These gaps drive interest in so‐called liquid biopsy approaches for HNC detection, prognostication, and surveillance.
Patricia J. Brooks, Scott V. Bratman
wiley   +1 more source

Systemic Risks of Topical Anesthetics in Barrier-Compromised Dermatologic Patients. [PDF]

open access: yesCureus
Chamoun G   +6 more
europepmc   +1 more source

Mitigation and management of adverse events associated with amivantamab therapy. [PDF]

open access: yesOncologist
Florez N   +13 more
europepmc   +1 more source

ANTIBIOTICS USED AS ANTI-INFLAMMATORY AND IMMUNOMODULATORY AGENTS IN DERMATOLOGICAL DISORDERS

open access: gold, 2018
Showkath Ali S   +3 more
openalex   +1 more source

Twenty‐year survival outcomes after multipeptide vaccination for resected high‐risk melanoma: A post‐hoc analysis of a randomized clinical trial

open access: yesInternational Journal of Cancer, EarlyView.
What's New? While melanoma vaccines have shown therapeutic promise, predicting their clinical benefits is challenged by factors such as delayed response to immunotherapy and scarcity of biomarkers. Here, the authors examined the long‐term efficacy of vaccination with either 4 or 12 class I MHC‐restricted peptides in high‐risk melanoma.
Emily K. Ninmer   +3 more
wiley   +1 more source

Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real‐life worldwide population

open access: yesInternational Journal of Cancer, EarlyView.
What's new? In recent years, the possible prognostic impact of concomitant medications in patients with cancer treated with immunotherapy combinations has generated increasing interest. This real‐world analysis evaluated the impact of concomitant medications on survival outcomes in patients with advanced biliary tract cancer treated with cisplatin ...
Federica Lo Prinzi   +71 more
wiley   +1 more source

Home - About - Disclaimer - Privacy